Expression, purification, and characterization of the 4 zinc finger region of human tumor suppressor WT1

Protein Expression and Purification

Volumn 46, Issue 2, 2006, Pages 379-389

  Nurmemmedov, Elmar ^a   Thunnissen, Marjolein ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Protein DNA complex; Purification; Refolding; Secondary structure; WT1; Zinc finger

Indexed keywords

HYBRID PROTEIN; ISOPROTEIN; WT1 PROTEIN; ZINC FINGER PROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; BIOSYNTHESIS; CHEMISTRY; ESCHERICHIA COLI; GENE EXPRESSION; GENETICS; HUMAN; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; METHODOLOGY; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN TERTIARY STRUCTURE;

ALTERNATIVE SPLICING; CHROMATOGRAPHY, LIQUID; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT FUSION PROTEINS; WT1 PROTEINS; ZINC FINGERS;

ESCHERICHIA COLI;

EID: 33645408053     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2005.10.029     Document Type: Article

References (35)

1. D.A. Haber, A.J. Buckler, T. Glaser, K.M. Call, J. Pelletier, R. Sohn, E.C. Gouglass, and D.E. Housman An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilm's Tumor Cell 61 1990 1257 1269
2. M. Gessler, A. Poustka, W. Cavenee, R.L. Neve, S.H. Orkin, and G.A. Bruns Homozygous deletion in Wilms Tumours of a zinc-finger gene identified by chromosome jumping Nature 343 1990 774 778
3. K.D. Wagner, N. Wagner, and A. Schedl The complex life of WT1 J. Cell Sci. 116 2003 1653 1658
4. A.W. Moore, M. Lesley, K. Jordan, D.H. Nicholas, and S. Andreas YAC complementation shows a requirement for WT1in the development of epicardium, adrenal gland, and throughout nephrogenesis Development 126 1999 1845 1857
5. K.D. Wagner, N. Wagner, V.P. Vidal, G. Schley, D. Wilhelm, A. Schedl, C. Englert, and H. Scholz The Wilms' Tumor gene WT1 is required for normal development of the retina EMBO J. 21 2002 1398 1405
6. J. Pelletier, W. Bruening, C.E. Kashtan, S.M. Mauer, J.C. Manivel, J.R. Striegel, D.C. Houghton, C. Junien, R. Habib, L. Fouser, R.N. Fine, B.L. Silverman, D.A. Haber, and D. Housman Germline mutations in the Wilm's Tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome Cell 67 1991 437 447
7. S. Barbaux, P. Niaudet, M.C. Gubler, J.P. Grunfeld, F. Jaubert, C.N. Kuttenn, N. Soulereau-Therville, M. Fellous, and K. McElreavey Donor splice mutations in WT1 are responsible fro Frasier Syndrome Nat. Genet. 17 1997 467 470
8. K. Inoue, H. Sugiyama, H. Ogawa, M. Nakagawa, T. Yamagami, H. Miwa, K. Kita, A. Hiraoka, T. Masaoka, K. Nassu, T. Kyo, H. Dohy, H. Naksuchi, T. Ishidate, T. Akiyama, and T. Kishimoto WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia Blood 84 1994 3071 3079
9. H. Tamaki, H. Ogawa, K. Ohyashiki, J.H. Ohyashiki, H. Iwama, K. Inoue, T. Soma, Y. Oka, T. Tatekawa, Y. Oji, A. Tsuboi, E.H. Kim, M. Kawakami, K. Fuchigami, M. Tomonaga, K. Toyama, K. Aozasa, T. Kishimoto, and H. Sugiyama The Wilm's Tumor gene WT1 is a good marker for diagnosis of disease progression of myelodyplastic syndromes Leukemia 13 1999 393 399
10. M.E. Lae, P.C. Roche, L. Jin, R.V. Lloyd, and A.G. Nascimento Desmoplastic small round cell tumor: a clinicopathologic, immunohistochemical, and molecular study of 32 tumors Am. J. Surg. Pathol. 26 2002 823 835
11. Y. Oji, S. Miyoshi, H. Maeda, S. Hayashi, H. Tamaki, S. Nakatsuka, M. Yao, E. Takahashi, Y. Nakano, H. Hirabayashi, Y. Shintani, Y. Oka, A. Tsuboi, N. Hosen, M. Asada, T. Fujioka, M. Murakami, K. Kanato, M. Motomura, E.H. Kim, M. Kawakami, K. Ikegame, H. Ogawa, K. Aozasa, I. Kawase, and H. Sugiyama Overexpression of the Wilm's Tumor gene WT1 in de novo lung cancers Int. J. Cancer 100 2002 297 303
12. D.M. Loeb, and S. Sukumar The Role of WT1 in Oncogenesis: tumor Suppressor or Oncogene? Int. J. Hematol. 76 2002 117 126
13. H. Youqi, S. Serban, L. Jiu, and D.M. Mark Transcriptional activation of c-myc proto-oncogene by WT1 protein Oncogene 23 2004 6933 6941
14. H. Sugiyama Wilm's Tumor gene WT1: its oncogenic function and clinical application Int. J. Hematol. 73 2001 1777 2187
15. A. Ward, J. Pooler, K. Miyagawa, A. Duarte, N.D. Hastie, and A. Caricasole Repression of promoters for mouse insulin-like factor II-encoding gene (Igf-2) by products of the Wilm's Tumor suppressor gene wt1 Gene 167 1995 239 243
16. M.W. Mayo, C.Y. Wang, S.S. Drouin, L.V. Madrid, A.F. Marshall, J.C. Reed, B.E. Weismann, and A.S. Baldwin WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene EMBO J. 18 1999 3990 4003
17. C. Englert, S. Maheswaran, A.J. Garvin, J. Krediberg, and D.A. Haber Induction of p21 by the Wilm's Tumor suppressor gene WT1 Cancer Res. 57 1997 1429 1434
18. P.R. Vajjhala, E. Macmillan, T. Gonda, and M. Little The Wilm's Tumour suppressor protein, WT1, undergoes CRM1-independent nucleocytoplasmic shuttling FEBS Lett. 554 2003 143 148
19. S.H. Larsson, J.P. Charlieu, K. Miyagawa, D. Engelkamp, M. Raszoulzadegan, A. Ross, F. Cuzin, V. van Heyningen, and N.D. Hastie Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing Cell 81 1995 391 401
20. R.C. Davies, C. Calvio, E. Bratt, S.H. Larsson, A.I. Lamond, and N.D. Hastie WT1 interacts with the splicing factor U2AF65 in an isoform-dependent manner and can be incorporated into spliceosomes Genes Dev. 12 1998 3217 3225
21. D.A. Haber, R.L. Sohn, A.J. Buckler, J. Pelletier, K.M. Call, and D.E. Housman Alternative splicing and genomic structure of the Wilm's Tumor gene WT1 Proc. Natl. Acad. Sci. USA 88 1991 9618 9622
22. V. Scharnhorst, A.J. van der Eb, and A.G. Jochemsen WT1 proteins: functions in growth and differentiation Gene 273 2001 141 161
23. A. Caricasole, A. Duante, S.H. Larsson, N.D. Hastie, M. Little, G. Holmes, I. Todorov, and A. Ward RNA binding by the Wilms Tumor suppressor zinc finger proteins Proc. Natl. Acad. Sci. USA 93 1996 7562 7566
24. N. Bardeesy, and J. Pelletier Overlapping RNA and DNA binding domains of the wt1 tumour suppressor gene product Nucleic Acids Res. 26 1998 1784 1792
25. P.A. Reynolds, A.S. Gromoslaw, R.E. Palmer, D. Sgroi, V. Yajnik, W. Gerald, and D.A. Haber Identification of a DNA-binding site and transcriptional target for the EWS-WT1 (+KTS) oncogene Genes Dev. 17 2003 2094 2107
26. K. Malik, P. Yan, T.H. Huang, and K.W. Brown Wilm's Tumor: a paradigm for the new genetics Oncol. Res. 12 2000 441 449
27. S.B. Lee, and D.A. Haber Wilms Tumor and the WT1 gene Exp. Cell Res. 264 2001 74 99
28. J.H. Laity, J. Chung, H.J. Dyson, and P.E. Wright Alternative splicing of Wilm's Tumor suppressor protein modulates DNA binding activity through isoform-specific DNA-induced conformational changes Biochemistry 29 2000 5341 5348
29. J.H. Laity, H.J. Dyson, and P.E. Wright DNA-induced alpha-helix capping in conserved linker sequences is a determinant of binding affinity in Cys(2)-His(2) zinc fingers J. Mol. Biol. 295 2000 719 727
30. J.H. Laity, H.J. Dyson, and P.E. Wright Molecular basis for modulation of biological function by alternative splicing of the Wilms Tumor suppressor protein Proc. Natl. Acad. Sci. USA 97 2000 11932 11935
31. N.J. Greenfield Methods to estimate the conformation of proteins and polypeptides from circular dichroism data Anal. Biochem. 235 1996 1 10
32. S. Rhee, R.G. Martin, J.L. Rosner, and D.R. Davies A novel DNA-binding motif in MarA: the first structure for an AraC family transcriptional activator Proc. Natl. Acad. Sci. USA 95 1998 10413 10418
33. I. Rouzina, K. Pant, R.L. Karpel, and M.C. Williams Theory of electrostatically regulated binding of T4 gene 32 protein to single- and double-stranded DNA Biophys. J. 89 2005 1941 1956
34. N.P. Pavletich, and C.O. Pabo Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex Science 252 1991 809 817
35. N.P. Pavletich, and C.O. Pabo Crystal structure of a five-finger GLI-DNA complex: new perspectives on zinc fingers Science 261 1993 1701 1707